Keywords: bayer, opts, into, arris, tryptase, inhibitor, asthma

Bayer Opts Into Arris' Tryptase Inhibitor For Asthma

Article | 21 October 1996

Print This

Bayer has started development of a tryptase inhibitor for asthma which was first identified by Arris Pharmaceutical. The move results ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in